# Immunomedics, Inc. (IMMU) Source: https://www.quantisnow.com/company/IMMU Generated: 2026-11-11T03:54:35.310Z - Ticker: IMMU - Exchange: NASDAQ - Sector: Health Care - Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances - IPO year: n/a ## Latest IMMU news and filings - 2026-06-25 08:48 UTC [FDA Approval for TRODELVY issued to IMMUNOMEDICS INC](https://www.quantisnow.com/insight/fda-approval-for-trodelvy-issued-to-immunomedics-inc-6614914) - 2026-06-25 08:48 UTC [FDA Approval for TRODELVY issued to IMMUNOMEDICS INC](https://www.quantisnow.com/insight/fda-approval-for-trodelvy-issued-to-immunomedics-inc-6614912) - 2024-11-25 09:48 UTC [FDA Approval for TRODELVY issued to IMMUNOMEDICS INC](https://www.quantisnow.com/insight/fda-approval-for-trodelvy-issued-to-immunomedics-inc-5789260) - 2024-04-15 13:00 UTC [Leadership Update] [NorthStar Appoints Peter Pfreundschuh to Board of Managers](https://www.quantisnow.com/insight/northstar-appoints-peter-pfreundschuh-to-board-of-managers-5409813) - 2023-02-03 16:40 UTC [FDA Approval for TRODELVY issued to IMMUNOMEDICS INC](https://www.quantisnow.com/insight/fda-approval-for-trodelvy-issued-to-immunomedics-inc-4001221) - 2022-06-06 08:34 UTC [FDA Approval for TRODELVY issued to IMMUNOMEDICS INC](https://www.quantisnow.com/insight/fda-approval-for-trodelvy-issued-to-immunomedics-inc-2989692) - 2021-04-14 09:15 UTC [FDA Approval for TRODELVY issued to IMMUNOMEDICS INC](https://www.quantisnow.com/insight/fda-approval-for-trodelvy-issued-to-immunomedics-inc-614841) - 2021-04-08 09:07 UTC [FDA Approval for TRODELVY issued to IMMUNOMEDICS INC](https://www.quantisnow.com/insight/fda-approval-for-trodelvy-issued-to-immunomedics-inc-598609) - 2021-04-08 09:07 UTC [FDA Approval for TRODELVY issued to IMMUNOMEDICS INC](https://www.quantisnow.com/insight/fda-approval-for-trodelvy-issued-to-immunomedics-inc-598608) - 2021-02-16 20:30 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-401128) - 2020-12-01 12:30 UTC [Leadership Update] [Frequency Therapeutics Appoints Peter Pfreundschuh as Chief Financial Officer](https://www.quantisnow.com/insight/frequency-therapeutics-appoints-peter-pfreundschuh-as-chief-financial-officer-189962) - 2020-11-05 14:15 UTC [Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors](https://www.quantisnow.com/insight/processa-pharmaceuticals-announces-the-appointment-of-dr-khalid-islam-to-140409) - 2020-10-23 13:15 UTC [Gilead Sciences Completes Acquisition of Immunomedics, Inc. ](https://www.quantisnow.com/insight/gilead-sciences-completes-acquisition-of-immunomedics-inc-116551) - 2020-10-20 09:01 UTC [ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics](https://www.quantisnow.com/insight/proteonic-announces-licensing-of-technology-for-production-of-biologics-to-107584) - 2020-10-06 03:02 UTC [ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - CBMG, VRTU, MR, IMMU, JCAP](https://www.quantisnow.com/insight/alert-halper-sadeh-llp-continues-to-investigate-the-following-mergers-83306) - 2020-10-03 00:55 UTC [WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations](https://www.quantisnow.com/insight/weisslaw-llp-reminds-mr-immu-and-bmch-shareholders-about-its-80822) - 2020-10-01 15:35 UTC [Moore Kuehn Encourages IMMU, MOBL, MR, and SCBH Investors to Contact Law Firm](https://www.quantisnow.com/insight/moore-kuehn-encourages-immu-mobl-mr-and-scbh-investors-to-78225) - 2020-09-26 02:55 UTC [WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations](https://www.quantisnow.com/insight/weisslaw-llp-reminds-mr-immu-and-bmch-shareholders-about-its-68779) - 2020-09-26 02:35 UTC [SHAREHOLDER ALERT: WeissLaw LLP Reminds AKCA, IMMU, and MXIM Shareholders About Its Ongoing Investigations](https://www.quantisnow.com/insight/shareholder-alert-weisslaw-llp-reminds-akca-immu-and-mxim-shareholders-68769) - 2020-09-21 01:45 UTC [(IMMU) Alert: Johnson Fistel Investigates Proposed Sale of Immunomedics; Is $88 a Fair Price?](https://www.quantisnow.com/insight/immu-alert-johnson-fistel-investigates-proposed-sale-of-immunomedics-is-57455) - 2020-09-19 15:00 UTC [Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer](https://www.quantisnow.com/insight/immunomedics-announces-positive-results-from-pivotal-phase-2-trophy-u-01-57329) - 2020-09-19 14:30 UTC [Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer](https://www.quantisnow.com/insight/trodelvy-significantly-extends-survival-in-phase-3-ascent-study-of-57327) - 2020-09-16 17:29 UTC [Lifshitz Law Firm, P.C. Announces Investigation of Immunomedics, Inc. (NASDAQ: IMMU), Livongo Health, Inc. (NASDAQ:LVGO), Varian Medical Systems, Inc. (NYSE: VAR) and Virtusa Corporation (NASDAQ: VRTU)](https://www.quantisnow.com/insight/lifshitz-law-firm-pc-announces-investigation-of-immunomedics-inc-nasdaq-52526) - 2020-09-16 12:45 UTC [Nanomedicine Seen As A Promising Approach For Diagnosis and Treatment Against COVID](https://www.quantisnow.com/insight/nanomedicine-seen-as-a-promising-approach-for-diagnosis-and-treatment-51634) - 2020-09-15 17:52 UTC [Moore Kuehn Encourages IMMU, ONDK, VRTU, and OTEL Investors to Contact Law Firm](https://www.quantisnow.com/insight/moore-kuehn-encourages-immu-ondk-vrtu-and-otel-investors-to-49959) - 2020-09-15 17:35 UTC [ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm](https://www.quantisnow.com/insight/alert-halper-sadeh-llp-is-investigating-the-following-mergers-shareholders-49913) - 2020-09-14 23:00 UTC [SHAREHOLDER ALERT: WeissLaw LLP Investigates Immunomedics, Inc.](https://www.quantisnow.com/insight/shareholder-alert-weisslaw-llp-investigates-immunomedics-inc-47552) - 2020-09-14 02:01 UTC [Immunomedics Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Immunomedics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – IMMU](https://www.quantisnow.com/insight/immunomedics-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-45314) - 2020-09-13 19:01 UTC [Gilead Sciences to Acquire Immunomedics](https://www.quantisnow.com/insight/gilead-sciences-to-acquire-immunomedics-45249) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/IMMU - Earnings history: https://www.quantisnow.com/earnings/IMMU - Dividend history: https://www.quantisnow.com/dividends/IMMU - Insider transactions: https://www.quantisnow.com/insiders/IMMU - Options chain: https://www.quantisnow.com/options/IMMU - SEC 8-K filings only: https://www.quantisnow.com/company/IMMU/8-k - RSS and alerts for IMMU: https://www.quantisnow.com/docs/rss-feeds.md